Published in Gut on April 28, 2006
PediCRaFT: Pediatric Crohn's Disease Fecal Transplant Trial (PediCRaFT) | NCT03378167
Salmonella enterica serovar typhimurium exploits inflammation to compete with the intestinal microbiota. PLoS Biol (2007) 7.58
Inflammatory bowel disease. Annu Rev Immunol (2010) 7.10
16S rRNA gene-based analysis of fecal microbiota from preterm infants with and without necrotizing enterocolitis. ISME J (2009) 3.75
Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut (2012) 2.60
High prevalence of Escherichia coli belonging to the B2+D phylogenetic group in inflammatory bowel disease. Gut (2006) 2.43
Crohn's disease-associated adherent-invasive E. coli are selectively favoured by impaired autophagy to replicate intracellularly. Cell Microbiol (2009) 2.23
Probiotics and the gut microbiota in intestinal health and disease. Nat Rev Gastroenterol Hepatol (2010) 2.22
Role of the gut microbiota in defining human health. Expert Rev Anti Infect Ther (2010) 1.73
Crohn's disease adherent-invasive Escherichia coli colonize and induce strong gut inflammation in transgenic mice expressing human CEACAM. J Exp Med (2009) 1.71
Complete genome sequence of Crohn's disease-associated adherent-invasive E. coli strain LF82. PLoS One (2010) 1.69
Antibiotic Exposure and Juvenile Idiopathic Arthritis: A Case-Control Study. Pediatrics (2015) 1.56
Alterations in the gut microbiome of children with severe ulcerative colitis. Inflamm Bowel Dis (2011) 1.42
Postsurgical recurrence of ileal Crohn's disease: an update on risk factors and intervention points to a central role for impaired host-microflora homeostasis. World J Surg (2010) 1.41
Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota. BMC Gastroenterol (2010) 1.41
Increased proportions of Bifidobacterium and the Lactobacillus group and loss of butyrate-producing bacteria in inflammatory bowel disease. J Clin Microbiol (2013) 1.34
The role of bacteria and pattern-recognition receptors in Crohn's disease. Nat Rev Gastroenterol Hepatol (2011) 1.27
Crohn disease: a current perspective on genetics, autophagy and immunity. Autophagy (2011) 1.26
Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years? World J Gastroenterol (2014) 1.25
Immunopathogenesis of inflammatory bowel disease. Self Nonself (2011) 1.24
Structural shifts of mucosa-associated lactobacilli and Clostridium leptum subgroup in patients with ulcerative colitis. J Clin Microbiol (2006) 1.22
Real-time analysis of mucosal flora in patients with inflammatory bowel disease in India. J Clin Microbiol (2010) 1.18
Probiotics and prebiotics in inflammatory bowel disease: microflora 'on the scope'. Br J Clin Pharmacol (2008) 1.18
A distinctive 'microbial signature' in celiac pediatric patients. BMC Microbiol (2010) 1.14
Mucosal bacterial microflora and mucus layer thickness in adolescents with inflammatory bowel disease. World J Gastroenterol (2009) 1.12
Reduced mucosal antimicrobial activity in Crohn's disease of the colon. Gut (2007) 1.11
Cathelicidin signaling via the Toll-like receptor protects against colitis in mice. Gastroenterology (2011) 1.09
Higher prevalence and abundance of Bdellovibrio bacteriovorus in the human gut of healthy subjects. PLoS One (2013) 1.06
Abnormally expressed ER stress response chaperone Gp96 in CD favours adherent-invasive Escherichia coli invasion. Gut (2010) 1.05
The dynamic distribution of porcine microbiota across different ages and gastrointestinal tract segments. PLoS One (2015) 1.03
Cross-sectional and longitudinal comparisons of the predominant fecal microbiota compositions of a group of pediatric patients with cystic fibrosis and their healthy siblings. Appl Environ Microbiol (2011) 1.01
Reduced diversity and increased virulence-gene carriage in intestinal enterobacteria of coeliac children. BMC Gastroenterol (2008) 1.00
Dysbiosis of gut fungal microbiota is associated with mucosal inflammation in Crohn's disease. J Clin Gastroenterol (2014) 0.99
Cystic fibrosis transmembrane conductance regulator (CFTR) allelic variants relate to shifts in faecal microbiota of cystic fibrosis patients. PLoS One (2013) 0.99
The dormant blood microbiome in chronic, inflammatory diseases. FEMS Microbiol Rev (2015) 0.99
Intestinal barrier in inflammatory bowel disease. World J Gastroenterol (2014) 0.97
Role of bacteria in the etiopathogenesis of inflammatory bowel disease. World J Gastroenterol (2007) 0.97
Ectopic expression of blood type antigens in inflamed mucosa with higher incidence of FUT2 secretor status in colonic Crohn's disease. J Gastroenterol (2011) 0.97
Disrupted intestinal microbiota and intestinal inflammation in children with cystic fibrosis and its restoration with Lactobacillus GG: a randomised clinical trial. PLoS One (2014) 0.96
Bacterial-mucosal interactions in inflammatory bowel disease: an alliance gone bad. Am J Physiol Gastrointest Liver Physiol (2008) 0.96
Microbial control of regulatory and effector T cell responses in the gut. Curr Opin Immunol (2010) 0.96
Evidence for the involvement of infectious agents in the pathogenesis of Crohn's disease. World J Gastroenterol (2008) 0.95
Functional metagenomics reveals novel pathways of prebiotic breakdown by human gut bacteria. PLoS One (2013) 0.95
Identification and characterisation of Pseudomonas 16S ribosomal DNA from ileal biopsies of children with Crohn's disease. PLoS One (2008) 0.95
Metagenomics Reveals Dysbiosis and a Potentially Pathogenic N. flavescens Strain in Duodenum of Adult Celiac Patients. Am J Gastroenterol (2016) 0.94
A role for the RNA chaperone Hfq in controlling adherent-invasive Escherichia coli colonization and virulence. PLoS One (2011) 0.94
Characterization of adherent bacteroidales from intestinal biopsies of children and young adults with inflammatory bowel disease. PLoS One (2013) 0.93
Possible role of Escherichia coli in propagation and perpetuation of chronic inflammation in ulcerative colitis. BMC Gastroenterol (2013) 0.93
Intestinal microbiota, probiotics and prebiotics in inflammatory bowel disease. World J Gastroenterol (2014) 0.92
Conversion of daidzein and genistein by an anaerobic bacterium newly isolated from the mouse intestine. Appl Environ Microbiol (2008) 0.92
Characterization of the gut-associated microbiome in inflammatory pouch complications following ileal pouch-anal anastomosis. PLoS One (2013) 0.92
The role of bacteria in the pathogenesis of ulcerative colitis. J Signal Transduct (2012) 0.91
Characterization of bacterial community shift in human Ulcerative Colitis patients revealed by Illumina based 16S rRNA gene amplicon sequencing. Gut Pathog (2014) 0.91
Why is initial bacterial colonization of the intestine important to infants' and children's health? J Pediatr Gastroenterol Nutr (2015) 0.90
Microevolution in fimH gene of mucosa-associated Escherichia coli strains isolated from pediatric patients with inflammatory bowel disease. Infect Immun (2012) 0.90
Rectal administration of Lactobacillus casei DG modifies flora composition and Toll-like receptor expression in colonic mucosa of patients with mild ulcerative colitis. Dig Dis Sci (2010) 0.89
Probiotics, nuclear receptor signaling, and anti-inflammatory pathways. Gastroenterol Res Pract (2011) 0.88
Microbiota separation and C-reactive protein elevation in treatment-naïve pediatric granulomatous Crohn disease. J Pediatr Gastroenterol Nutr (2012) 0.88
Isolated Lymphoid Follicles are Dynamic Reservoirs for the Induction of Intestinal IgA. Front Immunol (2012) 0.88
Dysbiotic events in gut microbiota: impact on human health. Nutrients (2014) 0.87
Differential effects of Bifidobacterium pseudolongum strain Patronus and metronidazole in the rat gut. Appl Environ Microbiol (2008) 0.86
Lactobacillus plantarum prevents the upregulation of adhesion molecule expression in an experimental colitis model. Dig Dis Sci (2009) 0.86
Fecal Microbiota in Patients with Irritable Bowel Syndrome Compared with Healthy Controls Using Real-Time Polymerase Chain Reaction: An Evidence of Dysbiosis. Dig Dis Sci (2015) 0.86
Adherent-invasive Escherichia coli (AIEC) in pediatric Crohn's disease patients: phenotypic and genetic pathogenic features. BMC Res Notes (2014) 0.85
Mucosal Barrier Depletion and Loss of Bacterial Diversity are Primary Abnormalities in Paediatric Ulcerative Colitis. J Crohns Colitis (2015) 0.85
99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: induction and control of regulatory T cells in the gastrointestinal tract: consequences for local and peripheral immune responses. Clin Exp Immunol (2010) 0.85
Efficacy profiles for different concentrations of Lactobacillus acidophilus in experimental colitis. World J Gastroenterol (2013) 0.84
Gut microbiome diversity in acute infective and chronic inflammatory gastrointestinal diseases in North India. J Gastroenterol (2016) 0.84
Bacterial superantigens and T cell receptor beta-chain-bearing T cells in the immunopathogenesis of ulcerative colitis. Clin Exp Immunol (2007) 0.83
Juvenile ferric iron prevents microbiota dysbiosis and colitis in adult rodents. World J Gastroenterol (2012) 0.83
Understanding how commensal obligate anaerobic bacteria regulate immune functions in the large intestine. Nutrients (2014) 0.83
Intestinal Host-Microbe Interactions under Physiological and Pathological Conditions. Int J Inflam (2010) 0.83
Western diet induces a shift in microbiota composition enhancing susceptibility to Adherent-Invasive E. coli infection and intestinal inflammation. Sci Rep (2016) 0.82
Relationship between pouch microbiota and pouchitis following restorative proctocolectomy for ulcerative colitis. World J Gastroenterol (2014) 0.82
Changes in composition of caecal microbiota associated with increased colon inflammation in interleukin-10 gene-deficient mice inoculated with Enterococcus species. Nutrients (2015) 0.82
Bacterial colonization and intestinal mucosal barrier development. World J Clin Pediatr (2013) 0.81
Novel Burkholderiales 23S rRNA genes identified in ileal biopsy samples from children: preliminary evidence that a subtype is associated with perianal Crohn's disease. J Clin Microbiol (2010) 0.80
Infectious etiopathogenesis of Crohn's disease. World J Gastroenterol (2014) 0.79
Lower Level of Bacteroides in the Gut Microbiota Is Associated with Inflammatory Bowel Disease: A Meta-Analysis. Biomed Res Int (2016) 0.78
Fecal microbial transplant for the treatment of pediatric inflammatory bowel disease. World J Gastroenterol (2016) 0.77
Influenza A virus infection of intestinal epithelial cells enhances the adhesion ability of Crohn's disease associated Escherichia coli strains. PLoS One (2015) 0.77
Anti-Outer membrane protein C and anti-glycoprotein 2 antibodies in inflammatory bowel disease and their association with complicated forms of Crohn's disease. BMC Gastroenterol (2014) 0.77
Trends and determinants of gastric bacterial colonization of preterm neonates in a NICU setting. PLoS One (2015) 0.77
Promises and paradoxes of regulatory T cells in inflammatory bowel disease. World J Gastroenterol (2015) 0.77
Paneth cell defects in Crohn's disease patients promote dysbiosis. JCI Insight (2016) 0.76
Secretion of Alpha-Hemolysin by Escherichia coli Disrupts Tight Junctions in Ulcerative Colitis Patients. Clin Transl Gastroenterol (2016) 0.76
Ribonucleotide reductase NrdR as a novel regulator for motility and chemotaxis during adherent-invasive Escherichia coli infection. Infect Immun (2015) 0.76
Innate immune responses to gut microbiota differ between oceanic and freshwater threespine stickleback populations. Dis Model Mech (2015) 0.75
The dual role of Escherichia coli in the course of ulcerative colitis. BMC Gastroenterol (2016) 0.75
Genome analysis of E. coli isolated from Crohn's disease patients. BMC Genomics (2017) 0.75
Teleosts as Model Organisms to Understand Host-Microbe Interactions. J Bacteriol (2017) 0.75
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature (2001) 33.12
Human fecal flora: the normal flora of 20 Japanese-Hawaiians. Appl Microbiol (1974) 20.50
Commensal host-bacterial relationships in the gut. Science (2001) 14.82
Gut flora in health and disease. Lancet (2003) 9.85
Mucosal flora in inflammatory bowel disease. Gastroenterology (2002) 8.42
Experimental models of inflammatory bowel disease. Gastroenterology (1995) 6.28
High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology (2004) 5.94
Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut (2004) 5.32
Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut (2003) 5.19
Dysbiosis in inflammatory bowel disease. Gut (2004) 5.01
Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology (2004) 4.89
PCR detection and quantitation of predominant anaerobic bacteria in human and animal fecal samples. Appl Environ Microbiol (1996) 4.10
Development of 16S rRNA-gene-targeted group-specific primers for the detection and identification of predominant bacteria in human feces. Appl Environ Microbiol (2002) 3.35
Mucosal and invading bacteria in patients with inflammatory bowel disease compared with controls. Scand J Gastroenterol (2002) 3.00
Biodiversity of the mucosa-associated microbiota is stable along the distal digestive tract in healthy individuals and patients with IBD. Inflamm Bowel Dis (2005) 2.93
Invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patient with Crohn's disease. Infect Immun (1999) 2.92
Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation. Gastroenterology (2002) 2.80
The intestinal mucus layer from patients with inflammatory bowel disease harbors high numbers of bacteria compared with controls. Gastroenterology (1999) 2.37
Mucin degradation in human colon ecosystems. Isolation and properties of fecal strains that degrade ABH blood group antigens and oligosaccharides from mucin glycoproteins. J Clin Invest (1985) 2.30
Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. Gut (1996) 2.23
The assessment of faecal flora in patients with inflammatory bowel disease by a simplified bacteriological technique. J Med Microbiol (1991) 1.88
Differential induction of colitis and gastritis in HLA-B27 transgenic rats selectively colonized with Bacteroides vulgatus or Escherichia coli. Infect Immun (1999) 1.85
Mucin degradation in the human colon: production of sialidase, sialate O-acetylesterase, N-acetylneuraminate lyase, arylesterase, and glycosulfatase activities by strains of fecal bacteria. Infect Immun (1992) 1.78
Type 1 pili-mediated adherence of Escherichia coli strain LF82 isolated from Crohn's disease is involved in bacterial invasion of intestinal epithelial cells. Mol Microbiol (2001) 1.73
Altered glycosylation in inflammatory bowel disease: a possible role in cancer development. Glycoconj J (2003) 1.61
The host-microbe interface within the gut. Best Pract Res Clin Gastroenterol (2002) 1.57
Anaerobic gram-negative faecal flora in patients with Crohn's disease and healthy subjects. Antonie Van Leeuwenhoek (1983) 1.56
Reactivity of infiltrating T lymphocytes with microbial antigens in Crohn's disease. Lancet (1991) 1.56
Adaptation of bacteria to the intestinal niche: probiotics and gut disorder. Inflamm Bowel Dis (2001) 1.56
Bacteroides vulgatus protects against Escherichia coli-induced colitis in gnotobiotic interleukin-2-deficient mice. Gastroenterology (2003) 1.53
Lack of support for a common etiology in Johne's disease of animals and Crohn's disease in humans. Inflamm Bowel Dis (1999) 1.49
Mucosa-associated bacterial flora of the human colon. J Med Microbiol (1997) 1.47
Regional distribution and alterations of lectin binding to colorectal mucin in mucosal biopsies from controls and subjects with inflammatory bowel diseases. J Clin Invest (1985) 1.42
Review article: gut flora and inflammatory bowel disease. Aliment Pharmacol Ther (2004) 1.36
Systemic antibodies towards mucosal bacteria in ulcerative colitis and Crohn's disease differentially activate the innate immune response. Gut (2004) 1.26
The rectal mucosa-associated microflora in patients with ulcerative colitis. J Med Microbiol (1992) 1.24
Dendritic cells and the intestinal bacterial flora: a role for localized mucosal immune responses. J Clin Invest (2003) 1.14
Interaction between resident luminal bacteria and the host: can a healthy relationship turn sour? J Pediatr Gastroenterol Nutr (2004) 1.10
Indeterminate colitis. Inflamm Bowel Dis (2003) 1.08
The microbial flora of the rectal mucosa and faeces of patients with Crohn's disease before and during antimicrobial chemotherapy. J Med Microbiol (1984) 1.07
Lymphonodular hyperplasia on the mucosa of the lower gastrointestinal tract in children: an indication of enhanced immune response? J Pediatr Gastroenterol Nutr (2002) 0.96
Chronic intestinal inflammation and seronegative spondyloarthropathy in children. Dig Liver Dis (2005) 0.88
Detection of Chlamydia pneumoniae by polymerase chain reaction-enzyme immunoassay in intestinal mucosal biopsies from patients with inflammatory bowel disease and controls. J Gastroenterol Hepatol (2002) 0.82
Childhood functional gastrointestinal disorders. Gut (1999) 2.38
Systematic review: gastric cancer incidence in pernicious anaemia. Aliment Pharmacol Ther (2012) 2.10
Odds ratio and relative risk for cross-sectional data. Int J Epidemiol (1995) 2.03
Cytomegalovirus infection. Viral ultrastructure with particular reference to the relationship of lysosomes to cytoplasmic inclusions. Am J Pathol (1966) 1.99
Conserved sequence motifs among bacterial, eukaryotic, and archaeal phosphatases that define a new phosphohydrolase superfamily. Protein Sci (1998) 1.93
Gastric electrical dysrhythmias and delayed gastric emptying in gastroesophageal reflux disease. Am J Gastroenterol (1997) 1.83
Short- and long-term therapeutic efficacy of nutritional therapy and corticosteroids in paediatric Crohn's disease. Dig Liver Dis (2005) 1.79
Diagnosis and treatment of chronic intestinal pseudo-obstruction in children: report of consensus workshop. J Pediatr Gastroenterol Nutr (1997) 1.79
Application of SOFA score to trauma patients. Sequential Organ Failure Assessment. Intensive Care Med (1999) 1.66
Endoscopy in dyspeptic patients: is gastric mucosal biopsy useful? Am J Gastroenterol (1990) 1.60
Headache and recurrent abdominal pain: a controlled study by the means of the Child Behaviour Checklist (CBCL). Cephalalgia (2007) 1.57
The role of cisapride in the treatment of pediatric gastroesophageal reflux. The European Society of Paediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr (1999) 1.56
Violacein and biofilm production in Janthinobacterium lividum. J Appl Microbiol (2007) 1.56
Travel-associated hepatitis A: effect of place of residence and country visited. J Public Health Med (1991) 1.51
Etiology and risk factors of severe and protracted diarrhea. J Pediatr Gastroenterol Nutr (1995) 1.49
Bacterial ratchet motors. Proc Natl Acad Sci U S A (2010) 1.49
Bacterial nonspecific acid phosphohydrolases: physiology, evolution and use as tools in microbial biotechnology. Cell Mol Life Sci (1998) 1.46
Esophageal motor abnormalities in children with gastroesophageal reflux and peptic esophagitis. J Pediatr (1986) 1.43
Laparoscopic versus traditional fundoplication in the treatment of children with refractory gastro-oesophageal reflux. Ital J Gastroenterol Hepatol (1997) 1.39
Integrative mechanisms of blood pressure regulation in humans and rats: cross-species similarities. Am J Physiol Regul Integr Comp Physiol (2010) 1.38
Invasion of cultured human cells by Streptococcus pyogenes. Res Microbiol (1995) 1.34
Systematic review: distribution of advanced neoplasia according to polyp size at screening colonoscopy. Aliment Pharmacol Ther (2009) 1.32
Entry pathway of vesicular stomatitis virus into different host cells. J Gen Virol (1987) 1.31
Current concepts and issues in the management of regurgitation of infants: a reappraisal. Management guidelines from a working party. Acta Paediatr (1996) 1.27
Targeted inhibition of mTORC1 and mTORC2 by active-site mTOR inhibitors has cytotoxic effects in T-cell acute lymphoblastic leukemia. Leukemia (2011) 1.26
Use of endoscopy in patients with dyspepsia. BMJ (1989) 1.24
Characterization and sequence of PhoC, the principal phosphate-irrepressible acid phosphatase of Morganella morganii. Microbiology (1994) 1.21
Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor perifosine in acute myelogenous leukemia cells. Leukemia (2007) 1.20
Cross-cultural considerations in clinical ethics consultations. Arch Fam Med (1995) 1.19
Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin module for acute myelogenous leukemia therapy: from bench to bedside. Curr Med Chem (2007) 1.19
Energy-saving gait mechanics with head-supported loads. Nature (1995) 1.18
Cytotoxic activity of the novel Akt inhibitor, MK-2206, in T-cell acute lymphoblastic leukemia. Leukemia (2012) 1.16
Bowel frequency in healthy children. Acta Paediatr Scand (1989) 1.16
Natural distribution of 5 bacteria associated with periodontal disease. J Clin Periodontol (1993) 1.14
Results of the laparoscopic Heller-Dor procedure for pediatric esophageal achalasia. Surg Endosc (2003) 1.13
Up-regulation of the IL-12 receptor beta 2 chain in Crohn's disease. J Immunol (2000) 1.13
Effect of cisapride on chronic idiopathic constipation in children. Dig Dis Sci (1991) 1.13
Contrast enhanced magnetic resonance imaging of the terminal ileum in children with Crohn's disease. Gut (2003) 1.13
Letter: atherosclerosis and coeliac disease--another feature of the changing paradigm? Aliment Pharmacol Ther (2013) 1.10
The effects of inhibitors of vacuolar acidification on the release of Listeria monocytogenes from phagosomes of Caco-2 cells. J Med Microbiol (1996) 1.09
Cisapride for gastro-oesophageal reflux and peptic oesophagitis. Arch Dis Child (1987) 1.08
Gastrointestinal transit time, frequency of defecation, and anorectal manometry in healthy and constipated children. J Pediatr (1985) 1.08
Eighteen month follow up of Helicobacter pylori positive children treated with amoxycillin and tinidazole. Gut (1992) 1.07
Letter: follow-up practices in coeliac disease--intestinal biopsy after child-to-adult transition might be useful. Aliment Pharmacol Ther (2014) 1.07
Cisapride restores the decreased lower oesophageal sphincter pressure in reflux patients. Gut (1988) 1.07
Disorders of oesophageal motility in children with psychomotor retardation and gastro-oesophageal reflux. Eur J Pediatr (1991) 1.07
Letter: coeliac disease and ischaemic heart disease--a true additional risk factor? Aliment Pharmacol Ther (2013) 1.07
Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease. Dig Liver Dis (2004) 1.04
Capacity of staphylococci to grow in the presence of ovotransferrin or CrCl3 as a character of potential pathogenicity. J Clin Microbiol (1980) 1.03
AMP-dependent kinase/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implications. Leukemia (2011) 1.02
A family of bombinin-related peptides from the skin of Bombina variegata. Eur J Biochem (1991) 1.02
Randomised clinical trial: the effectiveness of Lactobacillus reuteri ATCC 55730 rectal enema in children with active distal ulcerative colitis. Aliment Pharmacol Ther (2011) 1.00
Human polyomavirus JC reactivation and pathogenetic mechanisms of progressive multifocal leukoencephalopathy and cancer in the era of monoclonal antibody therapies. J Neurovirol (2012) 1.00
Residual insulin secretion at diagnosis of type 1 diabetes is independently associated with both, age of onset and HLA genotype. Diabetes Metab Res Rev (2005) 1.00
Association of DRB1*04-DQB1*0301 haplotype and lack of association of two polymorphic sites at CTLA-4 gene with Hashimoto's thyroiditis in an Italian population. Thyroid (2001) 0.99
Receptors for BK virus on human erythrocytes. Acta Virol (1981) 0.98
Risk factors for progression to gastric neoplastic lesions in patients with atrophic gastritis. Aliment Pharmacol Ther (2010) 0.98
An immunocytochemical analysis of torn rotator cuff tendon taken at the time of repair. J Shoulder Elbow Surg (2003) 0.98
Influence of vasopressin and angiotensin on baroreflexes in the dog. Circ Res (1984) 0.98
Campylobacter colitis in infants. J Pediatr (1983) 0.98
Idiopathic dilated cardiomyopathy associated with coeliac disease: the effect of a gluten-free diet on cardiac performance. Dig Liver Dis (2002) 0.98
Crohn's-like ileo-colitis in patients affected by glycogen storage disease Ib: two years' follow-up of patients with a wide spectrum of gastrointestinal signs. Acta Paediatr (2003) 0.97
[A mathematical model for the temperature effects on circadian rhythms]. J Theor Biol (1968) 0.97
Acid tolerance in Listeria monocytogenes influences invasiveness of enterocyte-like cells and macrophage-like cells. Microb Pathog (2000) 0.96
Regulation of the T helper cell type 1 transcription factor T-bet in coeliac disease mucosa. Gut (2004) 0.96
Polymorphism of the IRGM gene might predispose to fistulizing behavior in Crohn's disease. Am J Gastroenterol (2009) 0.95
Bronchial hyperresponsiveness in children and adolescents with Crohn's disease. Am J Respir Crit Care Med (2000) 0.95
Effect of isoflavans and isoflavenes on the infection of Frp/3 cells by hepatitis A virus. Antiviral Res (1989) 0.95
Identification of the gene (aphA) encoding the class B acid phosphatase/phosphotransferase of Escherichia coli MG1655 and characterization of its product. FEMS Microbiol Lett (1997) 0.95
Urothelial bladder carcinoma and viral infections: different association with human polyomaviruses and papillomaviruses. Int J Immunopathol Pharmacol (2003) 0.94
Cloning and characterization of the NapA acid phosphatase/phosphotransferase of Morganella morganii: identification of a new family of bacterial acid-phosphatase-encoding genes. Microbiology (1995) 0.94
Epidemiology of Chlamydia trachomatis endocervical infection in a previously unscreened population in Rome, Italy, 2000 to 2009. Euro Surveill (2012) 0.94
High-resolution colonic manometry accurately predicts colonic neuromuscular pathological phenotype in pediatric slow transit constipation. Neurogastroenterol Motil (2012) 0.93
Cross-cultural validity of FIM in spinal cord injury. Spinal Cord (2006) 0.93
Gastric emptying and myoelectrical activity in children with nonulcer dyspepsia. Effect of cisapride. Dig Dis Sci (1995) 0.93
Offset analgesia is mediated by activation in the region of the periaqueductal grey and rostral ventromedial medulla. Neuroimage (2009) 0.93
A critical appraisal of current management practices for infant regurgitation--recommendations of a working party. Eur J Pediatr (1997) 0.93
Inflammatory bowel disease in children and adolescents in Italy: data from the pediatric national IBD register (1996-2003). Inflamm Bowel Dis (2008) 0.92
Iron availability affects entry of Listeria monocytogenes into the enterocytelike cell line Caco-2. Infect Immun (1996) 0.91
Role of phospholipids in rhabdovirus attachment to CER cells. Brief report. Arch Virol (1984) 0.91
Sigmoidoscopy, colonoscopy, and radiology in the evaluation of children with rectal bleeding. J Pediatr Gastroenterol Nutr (1983) 0.90
Inhibition of herpes simplex virus infection by negatively charged and neutral carbohydrate polymers. J Chemother (1995) 0.90
Sequential evaluation of thiopurine methyltransferase, inosine triphosphate pyrophosphatase, and HPRT1 genes polymorphisms to explain thiopurines' toxicity and efficacy. Aliment Pharmacol Ther (2007) 0.90
Antacids and cimetidine treatment for gastro-oesophageal reflux and peptic oesophagitis. Arch Dis Child (1984) 0.90
Minocycline slow-release formulation effect on subgingival bacteria. J Periodontol (1992) 0.90
Disorders of upper esophageal sphincter motility in children. J Pediatr Gastroenterol Nutr (1988) 0.90
Plasmid-mediated fluoroquinolone resistance determinants in Escherichia coli from community uncomplicated urinary tract infection in an area of high prevalence of quinolone resistance. Eur J Clin Microbiol Infect Dis (2011) 0.90
Detection of Listeria monocytogenes in Italian-style soft cheeses. J Appl Microbiol (2003) 0.90
Domperidone is more effective than cisapride in children with diabetic gastroparesis. Aliment Pharmacol Ther (2002) 0.89
The association of MYO9B gene in Italian patients with inflammatory bowel diseases. Aliment Pharmacol Ther (2007) 0.89
Time to pregnancy and occupation in a group of Italian women. Int J Epidemiol (1997) 0.89
Antirotaviral activity of milk proteins: lactoferrin prevents rotavirus infection in the enterocyte-like cell line HT-29. Med Microbiol Immunol (1997) 0.89
Accuracy of breath tests using low doses of 13C-urea to diagnose Helicobacter pylori infection: a randomised controlled trial. Gut (2005) 0.88